PROFOUND MEDICAL CORP (PRN.CA) Stock Earnings & Estimates
Canada - Toronto Stock Exchange - TSX:PRN - CA74319B5027 - Common Stock
9.91 CAD
-0.04 (-0.4%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.681M -2.79% | 7.199M 7.75% | 10.68M 48.35% | 17.54M 64.23% | 37.37M 113.06% | 57.065M 52.70% | 78.446M 37.47% | 104.29M 32.94% | 254.09M 143.64% | 322.58M 26.96% | 399.95M 23.98% | |
| EBITDA YoY % growth | -27.998M 1.46% | -27.47M 1.89% | -32.126M -16.95% | -38.178M -18.84% | -25.503M 33.20% | -7.878M 69.11% | 26.768M 439.78% | 51.911M 93.93% | 110.07M 112.04% | 143.67M 30.53% | 181.24M 26.15% | |
| EBIT YoY % growth | -29.602M 2.27% | -28.616M 3.33% | -33.062M -15.54% | -43.699M -32.17% | -33.128M 24.19% | -20.251M 38.87% | -1.918M 90.53% | 12.216M 736.82% | 32.464M 165.75% | N/A | N/A | |
| Operating Margin | -443.08% | -397.50% | -309.57% | -249.14% | -88.65% | -35.49% | -2.45% | 11.71% | 12.78% | N/A | N/A | |
| EPS YoY % growth | -1.38 8.00% | -1.35 2.17% | -1.12 17.04% | -1.48 -32.56% | -1.05 29.25% | -0.60 42.79% | -0.07 88.25% | 0.95 1,451.50% | 2.48 160.29% | 3.25 30.91% | 4.12 26.69% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -41.40% | -0.27 25.65% | -0.24 54.36% | -0.22 14.54% | -0.20 30.36% | -0.20 24.53% | -0.12 48.94% | -0.06 72.73% | 0.00 100.00% |
| Revenue Q2Q % growth | 7.541M 80.54% | 7.474M 185.16% | 8.383M 279.15% | 9.797M 85.23% | 11.009M 45.99% | 12.387M 65.73% | 14.738M 75.81% | 17.357M 77.17% | 20.241M 83.86% |
| EBITDA Q2Q % growth | -5.959M 19.57% | -4.646M 57.78% | -3.333M 75.31% | -2.828M 66.58% | -7.479M -25.51% | -5.942M -27.89% | -3.502M -5.06% | -1.633M 42.25% | 400.97K 105.36% |
| EBIT Q2Q % growth | -8.652M -3.68% | -8.383M 24.92% | -7.828M 43.30% | -7.323M 17.84% | -6.565M 24.12% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.26 31.58% | -0.37 | 0.11 | 29.47% |
| Q2 2025 Q2Q % growth | -0.52 -85.71% | -0.37 | -0.15 | -40.10% |
| Q1 2025 Q2Q % growth | -0.36 -38.46% | -0.28 | -0.08 | -27.30% |
| Q4 2024 Q2Q % growth | -0.20 52.38% | -0.35 | 0.15 | 42.88% |
| Q3 2024 Q2Q % growth | -0.38 -46.15% | -0.30 | -0.08 | -28.63% |
| Q2 2024 Q2Q % growth | -0.28 20.00% | -0.29 | 0.01 | 5.06% |
| Q1 2024 Q2Q % growth | -0.26 18.75% | -0.28 | 0.02 | 6.39% |
| Q4 2023 Q2Q % growth | -0.42 8.70% | -0.32 | -0.10 | -30.15% |
| Q3 2023 Q2Q % growth | -0.26 -8.33% | -0.34 | 0.08 | 23.48% |
| Q2 2023 Q2Q % growth | -0.35 -25.00% | -0.36 | 0.01 | 2.34% |
| Q1 2023 Q2Q % growth | -0.32 20.00% | -0.36 | 0.04 | 11.99% |
| Q4 2022 Q2Q % growth | -0.46 6.12% | -0.37 | -0.09 | -23.09% |
| Q3 2022 Q2Q % growth | -0.24 17.24% | -0.37 | 0.13 | 35.19% |
| Q2 2022 Q2Q % growth | -0.28 20.00% | -0.40 | 0.12 | 29.52% |
| Q1 2022 Q2Q % growth | -0.40 -8.11% | -0.46 | 0.06 | 13.90% |
| Q4 2021 Q2Q % growth | -0.49 -28.94% | -0.34 | -0.15 | -45.55% |
| Q3 2021 Q2Q % growth | -0.29 10.17% | -0.27 | -0.02 | -8.35% |
| Q2 2021 Q2Q % growth | -0.35 -5.43% | -0.29 | -0.06 | -20.88% |
| Q1 2021 Q2Q % growth | -0.37 -98.84% | -0.27 | -0.10 | -39.15% |
| Q4 2020 Q2Q % growth | -0.38 -11.44% | -0.31 | -0.07 | -24.05% |
| Q3 2020 Q2Q % growth | -0.32 25.23% | -0.25 | -0.08 | -31.30% |
| Q2 2020 Q2Q % growth | -0.33 11.19% | -0.22 | -0.11 | -48.16% |
| Q1 2020 Q2Q % growth | -0.19 17.54% | -0.26 | 0.08 | 29.29% |
| Q4 2019 Q2Q % growth | -0.34 | -0.49 | 0.15 | 31.00% |
| Q3 2019 Q2Q % growth | -0.43 | -0.39 | -0.04 | -11.34% |
| Q2 2019 Q2Q % growth | -0.37 | -0.34 | -0.03 | -10.00% |
| Q1 2019 Q2Q % growth | -0.23 | -0.34 | 0.11 | 33.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 5.289M 86.76% | 5.044M | 245K | 4.86% |
| Q2 2025 Q2Q % growth | 2.211M -0.99% | 3.568M | -1.357M | -38.03% |
| Q1 2025 Q2Q % growth | 2.621M 37.23% | 3.535M | -914K | -25.86% |
| Q4 2024 Q2Q % growth | 4.177M 107.91% | 4.309M | -132K | -3.06% |
| Q3 2024 Q2Q % growth | 2.832M 63.89% | 2.91M | -78K | -2.68% |
| Q2 2024 Q2Q % growth | 2.233M 39.39% | 2.417M | -184K | -7.61% |
| Q1 2024 Q2Q % growth | 1.91M 2.69% | 2.82M | -910K | -32.27% |
| Q4 2023 Q2Q % growth | 2.009M 59.82% | 1.997M | 12K | 0.60% |
| Q3 2023 Q2Q % growth | 1.728M -15.09% | 2.087M | -359K | -17.20% |
| Q2 2023 Q2Q % growth | 1.602M -20.89% | 2.158M | -556K | -25.76% |
| Q1 2023 Q2Q % growth | 1.86M 36.36% | 2.238M | -378K | -16.89% |
| Q4 2022 Q2Q % growth | 1.257M 25.95% | 2.962M | -1.705M | -57.56% |
| Q3 2022 Q2Q % growth | 2.035M -19.79% | 2.224M | -189K | -8.50% |
| Q2 2022 Q2Q % growth | 2.025M -22.92% | 1.818M | 207K | 11.39% |
| Q1 2022 Q2Q % growth | 1.364M 91.84% | 2.19M | -826K | -37.72% |
| Q4 2021 Q2Q % growth | 998K -65.34% | 2.592M | -1.594M | -61.50% |
| Q3 2021 Q2Q % growth | 2.537M 13.36% | 3.886M | -1.349M | -34.71% |
| Q2 2021 Q2Q % growth | 2.627M 156.04% | 2.236M | 391K | 17.49% |
| Q1 2021 Q2Q % growth | 711K -38.71% | 2.612M | -1.901M | -72.78% |
| Q4 2020 Q2Q % growth | 2.879M 35.98% | 2.271M | 608.4K | 26.79% |
| Q3 2020 Q2Q % growth | 2.238M 333.05% | 1.837M | 401K | 21.83% |
| Q2 2020 Q2Q % growth | 1.026M 138.99% | 749.309K | 276.691K | 36.93% |
| Q1 2020 Q2Q % growth | 1.16M 4.47% | 882.023K | 277.977K | 31.52% |
| Q4 2019 Q2Q % growth | 2.118M | 2.073M | 44.5K | 2.15% |
| Q3 2019 Q2Q % growth | 516.8K | 1.179M | -662.2K | -56.17% |
| Q2 2019 Q2Q % growth | 429.3K | 983.316K | -554.016K | -56.34% |
| Q1 2019 Q2Q % growth | 1.11M | 780.972K | 329.428K | 42.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 21.68% | 5.16% | 4.08% |
| Revenue | 0% | 1.95% | 2.6% | 2.6% |